European Commission on Public Health defines rare diseases as
- life-threatening or chronically debilitating diseases which are of such low prevalence that special combined efforts are needed to address them -
Rare Insight Consulting
- will help new start-up biopharmaceutical companies establish their presence in Italy & Europe, as well as assisting well-established companies to bring solutions to people suffering from severe or orphan diseases. -
Rare Insight has been and is an extremely valuable partner for Laboratoires CTRS.
They have effectively supported us in all phases (early access, price & reimbursement, launch strategy and tactics in the Italian market, KOL mapping, effective presentation of Orphacol advantages to treating physicians) allowing Orphacol to reach 100% of eligible patients.
Marco Liguori – Head of International Commercial Operations